Latest Facility Acquisition News

Page 2 of 2
Paradigm Biopharmaceuticals has initiated dosing in its pivotal Phase 3 trial for knee osteoarthritis pain, backed by a strong cash position and strategic portfolio expansion. The company targets accelerated recruitment and a mid-2026 interim analysis.
Ada Torres
Ada Torres
30 Oct 2025
Black Cat Syndicate reported a 33% jump in gold production for the June quarter, driven by ramped-up operations and strategic acquisitions, with even stronger growth forecast for September despite scheduled maintenance.
Maxwell Dee
Maxwell Dee
3 July 2025
The Calmer Co. International Limited has secured a $2.64 million FJD loan from Fiji Development Bank to acquire a key Navua facility, marking a strategic step to bolster its kava processing and staff infrastructure.
Victor Sage
Victor Sage
14 Feb 2025